Table 5.
Outcome title | Number of studies | Number of patients | Effect size (SMD [95% CI]) | Test for overall effect p-value | Heterogeneity I² [%]; Tau² |
---|---|---|---|---|---|
Final treat-ment | |||||
01 Pain | 6 | 178 | -1.17 [-2.21, -0.13] | 0.03 | 88; 1.45 |
02 Fatigue | 1 | 12 | Not calculated | ||
03 Sleep | 2 | 66 | Not calculated | ||
04 Depressed mood | 1 | 12 | Not calculated | ||
05 HRQOL | 3 | 92 | -0.90 [-2.55, 0.76] | 0.29 | 91; 1.93 |
Follow up | |||||
01 Pain | 2 | 88 | Not calculated * | ||
02 Fatigue | 1 | 40 | Not calculated | ||
03 Sleep | 1 | 40 | Not calculated | ||
04 Depressed mood | 0 | 0 | |||
05 HRQOL | 1 | 48 | Not calculated |
Abbreviations: HRQOL: Health-related quality of life; SMD: Standardised mean difference; CI: Confidence interval
* Standard deviation of one study not available